OpenVSafe by OpenVAERS
Search V-safe

YSX-78663-92002

5 vaccinations 11 coded responses 41 check-ins 11 free-text entries 1 call case
Sex
Female
Age at first dose
51-55
ZIP prefix
481 / MI
Registered
2021-04-16
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-30
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-16
    Registered in v-safe
  3. 2021-04-16
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  4. 2021-04-20
    Dose 2 — Pfizer-BioNTech
  5. 2021-04-20
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  6. 2021-04-21
    Survey response — days 1–6 daily, dose 2
    MedDRA: Pruritus — Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: itchy but no rash
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-04-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fatigue or tiredness, Rash, not including the immediate area around the injection site
    Adult check-in
  8. 2021-04-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-04-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  10. 2021-04-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-04-27
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-05-04
    Survey response — day 14, dose 2
    MedDRA: Fatigue, Intermenstrual bleeding — Feeling: Fair
    Free text: Two days after 2nd dose I started menstruating. It is more like heavy spotting than a real period. It is lasting longer, so far 13 days. This is noticable for me because I am in perimenopause and my last cycle ended 262 days before. I am tired also.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-05-11
    Survey response — day 21, dose 2
    MedDRA: Intermenstrual bleeding, Vaccine positive rechallenge — Feeling: Good
    Free text: The menstrual spotting continued since last week and appears to be slowing down, today is the first day with none so far. I also had spotting starting 4 days after the 1st vaccine dose, it was much lighter and lasted only 4 days.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-05-18
    Survey response — day 28, dose 2
    MedDRA: Intermenstrual bleeding — Feeling: Good
    Free text: I continue to have menstrual spotting since my 2nd dose. It varies in volume, tapering off over several days to almost nothing then the next day with the higher volume spotting again. This is unusual for me.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-05-25
    Survey response — day 35, dose 2
    MedDRA: Intermenstrual bleeding — Feeling: Good
    Free text: The menstrual spotting continues since my last check-in.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-06-01
    Survey response — day 42, dose 2
    MedDRA: Unevaluable event — Feeling: Good
    Free text: Actually I have no new or worsening symptoms, but wanted to leave a comment. Since last week my menstrual spotting has stopped. It started a few days after the 2nd dose and lasted about 8 weeks.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-07-20
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-10-19
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-12-11
    Dose 3 — Pfizer-BioNTech
  20. 2022-01-17
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  21. 2022-01-22
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  22. 2022-03-12
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  23. 2022-04-15
    Dose 4 — Pfizer-BioNTech
  24. 2022-04-20
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Fatigue or tiredness, Rash, not including the immediate area around the injection site
    Adult check-in
  25. 2022-04-21
    Survey response — days 1–6 daily, dose 4
    MedDRA: Amenorrhoea, Intermenstrual bleeding — Feeling: Fair · Fatigue or tiredness, Rash, not including the immediate area around the injection site
    Free text: As with the first two shots, I again am having some light menstrual spotting. I have not had a menstrual cycle for the past 2 years.
    MedDRA releases: 2024-11 · check-in free text available
  26. 2022-04-22
    Health check-in — day 7, dose 4
    Feeling: Fair · Fatigue or tiredness, Rash, not including the immediate area around the injection site
    Adult check-in
  27. 2022-04-29
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  28. 2022-05-06
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  29. 2022-05-13
    Health check-in — day 28, dose 4
    Feeling: Fair
    Adult check-in
  30. 2022-07-15
    Survey response — 3 months, dose 4
    MedDRA: Acupuncture, Cough, Discharge, Fatigue, Musculoskeletal chest pain, Office visit, Sinus congestion — Feeling: Fair · Get care from a doctor or other healthcare professional
    Free text: Symptoms: Sinus congestion, drainage, fatigue, severe cough leading to rib pain, the recovery time was more than 1 month. · Healthcare visit (other): Chiropractic, Acupuncture
    MedDRA releases: 2024-11 · check-in free text available
  31. 2022-07-15
    Report sent to call center — 3 months, dose 4
    Get care from a doctor or other healthcare professional
    1 call case(s)
  32. 2022-07-18
  33. 2022-10-14
    Health check-in — 6 months, dose 4
    Feeling: Good
    Adult check-in
  34. 2022-10-15
    Dose 5 — Pfizer-BioNTech
  35. 2022-10-15
    Survey response — day 0, dose 5
    MedDRA: No adverse event — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: No
    MedDRA releases: 2024-11 · check-in free text available
  36. 2022-10-16
    Survey response — days 1–6 daily, dose 5
    MedDRA: Postmenopausal haemorrhage — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness
    Free text: Small amount of menstrual spotting despite being post menopausal
    MedDRA releases: 2024-11 · check-in free text available
  37. 2022-10-17
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · None
    Adult check-in
  38. 2022-10-18
    Health check-in — days 1–6 daily, dose 5
    Feeling: Fair · None
    Adult check-in
  39. 2022-10-19
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · None
    Adult check-in
  40. 2022-10-20
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · None
    Adult check-in
  41. 2022-10-21
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · None
    Adult check-in
  42. 2022-10-22
    Survey response — day 7, dose 5
    MedDRA: No adverse event — Feeling: Good · Fatigue or tiredness
    Free text: No
    MedDRA releases: 2024-11 · check-in free text available
  43. 2022-10-29
    Health check-in — day 14, dose 5
    Feeling: Good
    Adult check-in
  44. 2022-11-05
    Health check-in — day 21, dose 5
    Feeling: Fair
    Adult check-in
  45. 2022-11-12
    Health check-in — day 28, dose 5
    Feeling: Fair
    Adult check-in
  46. 2022-11-19
    Health check-in — day 35, dose 5
    Feeling: Good
    Adult check-in
  47. 2022-11-26
    Health check-in — day 42, dose 5
    Feeling: Good
    Adult check-in
  48. 2023-01-14
    Health check-in — 3 months, dose 5
    Feeling: Fair
    Adult check-in
  49. 2023-04-17
    Health check-in — 6 months, dose 5
    Feeling: Fair
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-30Pfizer-BioNTech
22021-04-20Pfizer-BioNTech
32021-12-11Pfizer-BioNTech No
42022-04-15Pfizer-BioNTech No
52022-10-15Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2022-07-15 Unsuccessful

Free text

Release 7 — days 1–6 daily, dose 2

2021-04-21

Systemic reaction (other): itchy but no rash

Release 8 — day 14, dose 2

2021-05-04

Symptoms: Two days after 2nd dose I started menstruating. It is more like heavy spotting than a real period. It is lasting longer, so far 13 days. This is noticable for me because I am in perimenopause and my last cycle ended 262 days before. I am tired also. cut off by CDC

Release 8 — day 21, dose 2

2021-05-11

Symptoms: The menstrual spotting continued since last week and appears to be slowing down, today is the first day with none so far. I also had spotting starting 4 days after the 1st vaccine dose, it was much lighter and lasted only 4 days.

Release 8 — day 28, dose 2

2021-05-18

Symptoms: I continue to have menstrual spotting since my 2nd dose. It varies in volume, tapering off over several days to almost nothing then the next day with the higher volume spotting again. This is unusual for me.

Release 8 — day 35, dose 2

2021-05-25

Symptoms: The menstrual spotting continues since my last check-in.

Release 8 — day 42, dose 2

2021-06-01

Symptoms: Actually I have no new or worsening symptoms, but wanted to leave a comment. Since last week my menstrual spotting has stopped. It started a few days after the 2nd dose and lasted about 8 weeks.

Release 11 — days 1–6 daily, dose 4

2022-04-21

Systemic reaction (other): As with the first two shots, I again am having some light menstrual spotting. I have not had a menstrual cycle for the past 2 years.

Release 12 — 3 months, dose 4

2022-07-15

Symptoms: Sinus congestion, drainage, fatigue, severe cough leading to rib pain, the recovery time was more than 1 month.
Healthcare visit (other): Chiropractic, Acupuncture

Release 12 — day 0, dose 5

2022-10-15

Systemic reaction (other): No

Release 12 — days 1–6 daily, dose 5

2022-10-16

Systemic reaction (other): Small amount of menstrual spotting despite being post menopausal

Release 12 — day 7, dose 5

2022-10-22

Systemic reaction (other): No

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOAcupuncture · · ✓
HCVOOffice visit · · ✓
SDCough · · ✓
SDDischarge · · ✓
SDFatigue ✓ ✓ ✓
SDIntermenstrual bleeding ✓ ✓ ✓
SDMusculoskeletal chest pain · · ✓
SDSinus congestion · · ✓
SDUnevaluable event ✓ ✓ ✓
SDVaccine positive rechallenge ✓ ✓ ✓
SROAmenorrhoea · · ✓
SROIntermenstrual bleeding · · ✓
SRONo adverse event · · ✓
SROPostmenopausal haemorrhage · · ✓
SROPruritus ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release